Inovio Pharmaceuticals
INO
#9821
Rank
C$0.11 B
Marketcap
C$1.37
Share price
-4.89%
Change (1 day)
-33.91%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$61.59 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are C$61.59 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$68.76 M7.22%
2024-12-31C$64.13 M-9.79%
2023-12-31C$71.09 M-58.47%
2022-12-31C$0.17 B39.54%
2021-12-31C$0.12 B22.37%
2020-12-31C$0.10 B-44.59%
2019-12-31C$0.18 B201.35%
2018-12-31C$60.04 M6.73%
2017-12-31C$56.26 M-16.81%
2016-12-31C$67.63 M28.62%
2015-12-31C$52.58 M123.8%
2014-12-31C$23.49 M-37.62%
2013-12-31C$37.66 M268.42%
2012-12-31C$10.22 M-24.11%
2011-12-31C$13.47 M50.32%
2010-12-31C$8.96 M-56.19%
2009-12-31C$20.45 M-15.37%
2008-12-31C$24.17 M177.24%
2007-12-31C$8.71 M-39.84%
2006-12-31C$14.49 M126%
2005-12-31C$6.41 M-1.16%
2004-12-31C$6.48 M323.4%
2003-12-31C$1.53 M-42.72%
2002-12-31C$2.67 M0.52%
2001-12-31C$2.66 M
2001-03-31C$2.51 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$168.69 B 273,773.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$112.17 B 182,023.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$165.17 B 268,067.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$46.28 B 75,048.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$116.61 B 189,228.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$84.81 B 137,597.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
C$2.35 B 3,719.21%๐Ÿ‡บ๐Ÿ‡ธ USA